Top Markets
Coin of the day
Anew Medical, Inc. Anew Medical, Inc.

Anew Medical, Inc.

WENA
Hisse Senetlerindeki Sıralama #33455
Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing... Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing innovative treatments for conditions affecting the brain and nervous system, age-related illnesses, and specialized diagnostic tools. Their pipeline includes advanced cell and gene therapies specifically designed to alleviate symptoms of aging-related conditions, such as dementia, Alzheimer's disease, and various neuromuscular disorders. Additionally, Anew Medical is engaged in developing biologics and biosimilars for cancer treatment, alongside research into therapies targeting melanocortin receptors. A key strategic alliance exists with Japan's Okinawa Research Center, focusing on the collaborative research and development of Klotho gene therapy. This initiative aims to extend human longevity and diminish the impact of age-related diseases. The company maintains its headquarters in Omaha, Nebraska.
Hisse Fiyatı
$0.5099
Son senkronizasyon: 2024-10-15
Piyasa Değeri
$7.60M
Değişim (1 gün)
2.02%
Değişim (1 yıl)
0.00%
Ülke
US
Ticaret Anew Medical, Inc. (WENA)

Kategori

Anew Medical, Inc. (WENA) için kazanç
Jun 2024 itibarıyla kazanç TTM: $114.12K
Anew Medical, Inc. şirketinin en son finansal raporlarına göre, mevcut kazancı $114.12K'dir. 2022 yılında şirket $1.56M kazanç elde etti, bu 2021 yılındaki $-1.11M kazanca göre önceki yıla göre artış. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Anew Medical, Inc. için kazanç geçmişi 2021 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
2026 (TTM) $114.12K -94.40%
2023 $2.04M 30.95%
2022 $1.56M -240.25%
2021 $-1.11M 0.00%
Benzer şirketler veya rakipler için kazanç
Şirket Kazanç Kazanç Farkı Ülke
$5.27B 4,622,261.26%
US
$1.95B 1,709,242.25%
NL
- -
CH
- -
KR
$3.01B 2,633,790.84%
BE